BackNKGen Biotech Overview

NKGen Biotech Profit Margin

Valuation check: NKGN's profit margin is -3612.58%, below the sector sector average of 21.34%.

Get informed when a big investor buys or sells

+ Follow

Quarterly Profit Margin

N/A

As of Mar 2025

Annual Profit Margin (TTM)

-3612.58%

Trailing 12 months ending Mar 2025

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading
Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin

NKGen Biotech (NKGN) FAQ

The latest profit margin for NKGN is -3612.58% as of March 2025. That is below the sector sector average of 21.34%. Investors often review this figure alongside NKGen Biotech's historical trend and sector peers before judging valuation or financial health.

Against its sector companies, NKGN currently prints -3612.58% for profit margin, while the sector average sits near 21.34%. That is roughly 17027.2% below the sector mean. Large gaps often invite a closer look at NKGen Biotech's growth, margins, and balance sheet.

Profit Margin shows how effectively NKGen Biotech converts resources into returns. At -3612.58%, NKGN may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting NKGN's profit margin (-3612.58%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.